Literature DB >> 7743661

Inhibition of ex vivo proinflammatory cytokine secretion in fatal Mycobacterium tuberculosis infection.

J S Friedland1, J C Hartley, C G Hartley, R J Shattock, G E Griffin.   

Abstract

Tuberculosis is characterized by fever, weight loss, a prolonged acute-phase protein response and granuloma formation. These characteristics may partly be due to action of proinflammatory cytokines tumour necrosis factor (TNF), IL-6 and IL-8. We investigated plasma concentrations of these cytokines before and after ex vivo lipopolysaccharide stimulation of whole blood leucocytes from 41 Zambian patients with tuberculosis, 32 of whom were also HIV+. Although patients had a reduced weight, were more anaemic and had higher erythrocyte sedimentation rate compared with controls (all P < 0.0005), clinical and laboratory measurements of disease state were similar in those who died and survivors. In contrast, plasma IL-6 and IL-8 concentrations were higher in patients who died (P < 0.05). There was no detectable cytokine mRNA in unstimulated leucocytes. There was reduced secretion of TNF (P < 0.005 at 2 h), IL-6 (P < 0.005 at 8 h) and IL-8 (P < 0.005 at 24 h) after ex vivo stimulation of whole blood leucocytes from patients who died compared with survivors. This was partly due to a soluble inhibitory factor present in plasma. The only additional effect of concurrent infection by HIV with Myco. tuberculosis was decreased IL-6 secretion following ex vivo stimulation of leucocytes. Reduced proinflammatory cytokine release may represent a critical impairment of host immune defences important in determining outcome in tuberculosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7743661      PMCID: PMC1534316          DOI: 10.1111/j.1365-2249.1995.tb03659.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  44 in total

1.  Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.

Authors:  J Gauldie; C Richards; D Harnish; P Lansdorp; H Baumann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

2.  Tuberculous lymphadenitis associated with human immunodeficiency virus (HIV) in Uganda.

Authors:  A Nambuya; N Sewankambo; J Mugerwa; R Goodgame; S Lucas
Journal:  J Clin Pathol       Date:  1988-01       Impact factor: 3.411

3.  The role of gamma-interferon, vitamin D3 metabolites and tumour necrosis factor in the pathogenesis of tuberculosis.

Authors:  G A Rook; J Taverne; C Leveton; J Steele
Journal:  Immunology       Date:  1987-10       Impact factor: 7.397

4.  Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections.

Authors:  M van Deuren; J van der Ven-Jongekrijg; P N Demacker; A K Bartelink; R van Dalen; R W Sauerwein; H Gallati; J L Vannice; J W van der Meer
Journal:  J Infect Dis       Date:  1994-01       Impact factor: 5.226

5.  Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura.

Authors:  E Girardin; G E Grau; J M Dayer; P Roux-Lombard; P H Lambert
Journal:  N Engl J Med       Date:  1988-08-18       Impact factor: 91.245

6.  Production and regulation of tumor necrosis factor alpha. A cellular and molecular analysis.

Authors:  S L Kunkel; M Spengler; G Kwon; M A May; D G Remick
Journal:  Methods Achiev Exp Pathol       Date:  1988

7.  Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome.

Authors:  J Lähdevirta; C P Maury; A M Teppo; H Repo
Journal:  Am J Med       Date:  1988-09       Impact factor: 4.965

8.  Adherence induces selective mRNA expression of monocyte mediators and proto-oncogenes.

Authors:  S Haskill; C Johnson; D Eierman; S Becker; K Warren
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

9.  B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes.

Authors:  M Lotz; F Jirik; P Kabouridis; C Tsoukas; T Hirano; T Kishimoto; D A Carson
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

10.  Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells.

Authors:  B Beutler; J Mahoney; N Le Trang; P Pekala; A Cerami
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

View more
  21 in total

1.  Opsonizing antibodies (IgG1) up-regulate monocyte proinflammatory cytokines tumour necrosis factor-alpha (TNF-alpha) and IL-6 but not anti-inflammatory cytokine IL-10 in mycobacterial antigen-stimulated monocytes-implications for pathogenesis.

Authors:  R Hussain; H Shiratsuchi; M Phillips; J Ellner; R S Wallis
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

2.  Grand rounds--Hammersmith Hospital. Persistent fever in pulmonary tuberculosis.

Authors:  M T Barakat; J Scott; J M Hughes; M Walport; J Calam; J S Friedland; P W Ind; C McKenna
Journal:  BMJ       Date:  1996-12-14

3.  Role of QuantiFERON-TB Gold antigen-specific IL-1β in diagnosis of active tuberculosis.

Authors:  Maddineni Prabhavathi; Basirudeen Syed Ahamed Kabeer; Anbarasu Deenadayalan; Alamelu Raja
Journal:  Med Microbiol Immunol       Date:  2014-12-11       Impact factor: 3.402

4.  Tumor necrosis factor-alpha, interleukin-6, and interleukin-8 secretion and the acute-phase response in patients with bacterial and tuberculous osteomyelitis.

Authors:  C A Evans; J Jellis; S P Hughes; D G Remick; J S Friedland
Journal:  J Infect Dis       Date:  1998-06       Impact factor: 5.226

5.  Down-regulation of interleukin-8 secretion from Mycobacterium tuberculosis-infected monocytes by interleukin-4 and -10 but not by interleukin-13.

Authors:  C Ameixa; J S Friedland
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

6.  The production of tumour necrosis factor-alpha is decreased in peripheral blood mononuclear cells from multidrug-resistant tuberculosis patients following stimulation with the 30-kDa antigen of Mycobacterium tuberculosis.

Authors:  J-S Lee; C-H Song; J-H Lim; H-J Kim; J-K Park; T-H Paik; C-H Kim; S-J Kong; M-H Shon; S-S Jung; E-K Jo
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

7.  Early secreted antigenic target of 6 kDa (ESAT-6) protein of Mycobacterium tuberculosis induces interleukin-8 (IL-8) expression in lung epithelial cells via protein kinase signaling and reactive oxygen species.

Authors:  Vijay Boggaram; Koteswara R Gottipati; Xisheng Wang; Buka Samten
Journal:  J Biol Chem       Date:  2013-07-18       Impact factor: 5.157

8.  Regulation of interleukin-8 by interleukin-10 and transforming growth factor beta in human monocytes infected with mycobacterium bovis.

Authors:  Patricia Méndez-Samperio; Elizabeth García; Abraham Vázquez; Janet Palma
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

Review 9.  Mycobacterium tuberculosis, macrophages, and the innate immune response: does common variation matter?

Authors:  William R Berrington; Thomas R Hawn
Journal:  Immunol Rev       Date:  2007-10       Impact factor: 12.988

10.  CCL2 responses to Mycobacterium tuberculosis are associated with disease severity in tuberculosis.

Authors:  Zahra Hasan; Jacqueline M Cliff; Hazel M Dockrell; Bushra Jamil; Muhammad Irfan; Mussarat Ashraf; Rabia Hussain
Journal:  PLoS One       Date:  2009-12-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.